Cai Ming, Yang Na, Lin Sha, Ye Bo, Chen Hui, Mao Wei-Lin
Clin Lab. 2021 Mar 1;67(3). doi: 10.7754/Clin.Lab.2020.200701.
Anemia is common in patients with severe chronic liver disease, but its role in HBV-related decompensated cirrhosis (DeCi) is still unclear. We therefore aimed to assess the impact of anemia on prognosis in HBV-DeCi patients.
One hundred thirty-three patients diagnosed with HBV-DeCi were retrospectively collected.
A total of 113 (85.0%) patients suffered from anemia in our cohort. The low hemoglobin (Hb) level group exhibited a significantly increased 28-day mortality rate compared with the high Hb group. Hb level was a predictor of 28-day mortality in HBV-DeCi patients.
Reduced Hb levels were associated with unfavorable prognosis in HBV-DeCi patients, and more attention should be paid to anemia in routine clinical assessments of liver cirrhosis.
贫血在严重慢性肝病患者中很常见，但其在乙型肝炎病毒（HBV）相关失代偿期肝硬化（DeCi）中的作用仍不清楚。因此，我们旨在评估贫血对HBV-DeCi患者预后的影响。
回顾性收集133例诊断为HBV-DeCi的患者。
在我们的队列中，共有113例（85.0%）患者患有贫血。与高血红蛋白（Hb）组相比，低Hb水平组的28天死亡率显著增加。Hb水平是HBV-DeCi患者28天死亡率的预测指标。
Hb水平降低与HBV-DeCi患者的不良预后相关，在肝硬化的常规临床评估中应更加关注贫血。
